NATALIE ALLISON: Open Payments
NPI 1164279105 · CHINA GROVE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$864 in 48 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $78 · 2025 $864
Food & beverage: $864
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $349 |
| Novo Nordisk Inc | 10 | $186 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| Organon LLC | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Exact Sciences Corporation | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| PFIZER INC. | 1 | $20 |
| Amgen Inc. | 1 | $19 |
Products named: QULIPTA, VRAYLAR, Wegovy, Ozempic, TRELEGY ELLIPTA, NEXPLANON, CAPLYTA, Rybelsus.
Industry payments across NC — which companies pay providers there.
